![]() |
市場調查報告書
商品編碼
2176819
人工智慧驅動的個人化護膚產品市場預測至2034年:全球產品類型、產品形態、應用、分銷管道、最終用戶、膚質和區域分析AI-Personalized Skincare Formulations Market Forecasts to 2034 - Global Analysis By Product Type, Product Form, Application, Distribution Channel, End User, Skin Type, and By Geography |
||||||
根據 Stratistics MRC 的數據,全球人工智慧驅動的個人化護膚配方市場預計將在 2026 年達到 14 億美元,並在預測期內以 12.5% 的複合年成長率成長,到 2034 年達到 36 億美元。
人工智慧驅動的個人化護膚配方,其配方由演算法決定。這些演算法分析個人皮膚數據,例如問卷調查、自拍照以及診斷設備的測量結果,從而選擇活性成分及其濃度。這些系統能夠生成精華液、客製化保濕霜以及針對痤瘡、色素沉著和皮膚屏障功能改善的個人化配方,所有產品均由演算法篩選。這些產品透過自動化配製和填充設備生產,並以精華液、乳霜、乳液、凝膠和面膜等形式呈現。此外,系統還會根據對乾性、油性和混合性皮膚的後續評估,定期對配方進行審查。
對個人化的期望不斷變化
消費者越來越傾向於選擇能夠滿足自身肌膚需求的客製化產品,而非大眾市場配方,這推動了演算法驅動型護膚的興起。品牌正將診斷問卷、智慧型手機影像和診所診斷設備的數據轉化為個人化配方,從而提升產品的相關性和滿意度。訂閱模式可根據肌膚狀況的變化調整配方,提高客戶留存率。這種從通用型購買轉向個人化購買的轉變,支撐了高階定價和持續收入,從而推動了D2C(直接面對消費者)和專業管道的品類擴張。
資料隱私和檢驗負擔
人工智慧驅動的個人化護膚依賴於收集高度敏感的臉部影像和皮膚健康數據,這在資料保護法規嚴格的地區增加了隱私合規義務。品牌需要實施用戶同意管理、安全儲存和透明的資料使用政策,這增加了成本和複雜性。此外,雖然演算法推薦需要經過檢驗以確保對所有膚質的安全性,但能夠證明其功效提升的獨立證據仍然有限。這些隱私和檢驗的負擔正在延緩市場准入,並限制標語,尤其是在歐洲和亞洲等嚴格的監管市場。
自動化混合基礎設施
自動化配製和填充系統使品牌能夠大規模生產個人化配方,無需人工配製,從而降低人事費用,並實現更貼近客戶的分散式生產。模組化生產單元可安裝在零售店、診所或區域履約中心,縮短交貨時間,提高產品新鮮度。隨著硬體成本的降低和配方庫的擴展,品牌可以提供更廣泛的客製化服務。此基礎設施支援定期訂閱模式,並改善D2C(直接面對消費者)和診所通路的利潤率結構。
使用精心挑選的零售產品進行替代
精心挑選的零售產品和精心設計的問卷式產品匹配系統,為消費者提供了一種更簡單、更經濟的方式來體驗「個人化」服務。許多消費者願意為演算法驅動的個人化服務支付溢價,因為他們接受精心挑選的推薦,而無需客製化專屬配方。如果知名品牌在其現有產品線中添加引導式診斷工具,那麼專注於個人化服務的平台可能難以脫穎而出。因此,倡導個人化服務的品牌必須展現出可衡量的績效優勢和更高的顧客留存率,才能保障其定價和客戶維繫。
疫情加速了消費者向線上諮詢和診斷測試的轉變,因為實體店購物受到限制。危機期間,品牌擴大了基於調查的個人護膚和直接送貨上門服務,以促進早期用戶接受度。疫情後,結合居家資料收集和診所檢驗的混合診斷模式需求增加,同時品牌加大了對隱私保護基礎設施和配方檢驗的投入,以應對日益嚴格的資料處理和功效聲明依據審查。
在預測期內,「客製化混合保濕霜」細分市場預計將佔據最大的市場佔有率。
由於「客製化保濕霜」產品日常使用頻率高、消費者對個人化保濕霜的廣泛接受度以及其適合訂閱式補貨模式,預計在預測期內,該細分市場將佔據最大的市場佔有率。與精華液相比,保濕霜的購買頻率更高,從而保證了穩定的收入和銷售。演算法可以根據膚質和季節變化調整脂質和保濕成分的比例,從而帶來顯著的效果。隨著品牌不斷拓展其配方研發體系,客製化保濕霜將繼續成為支撐該品類銷售的重要支柱,並保持其領先的銷售佔有率。
預計在預測期內,「血清」細分市場將實現最高的複合年成長率。
在預測期內,精華液細分市場預計將呈現最高的成長率,這主要得益於消費者對高濃度、快速吸收且能針對特定肌膚問題的產品形式的偏好,這些問題通常由診斷演算法識別出來。精華液使品牌能夠以更高的價格提供個人化的活性成分選擇和濃度,從而吸引消費者,這非常適合D2C(直接面對消費者)訂閱模式。隨著診斷準確性的提高和配方庫的不斷擴充,精華液的客製化發展速度在消費者和診所管道中均超過了其他產品形式。
在預測期內,北美預計將佔據最大的市場佔有率,這得益於其對數位化護膚的高度參與、成熟的D2C(直接面對消費者)基礎設施以及強大的個人化美妝平台。美國正引領區域銷售成長,這得益於創業投資資金支持的新創公司、自動化配製設施以及消費者樂於共用診斷數據。與藥局和專業零售商的合作進一步擴大了產品覆蓋範圍,並鞏固了北美在人工智慧驅動的個人化護膚配方領域的領先地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於中國、韓國、日本和印度智慧型手機的高普及率、電子商務的快速成長以及消費者對基於診斷數據的護膚的濃厚興趣。當地品牌正在推出由人工智慧驅動的客製化平台,並藉助自動化配方夥伴關係進行推廣。隨著中產階級消費能力的提升和皮膚科診所網路的不斷擴展,亞太地區已成為人工智慧驅動的個人化護膚配方領域成長最快的區域市場。
北美洲
我們
加拿大
墨西哥
歐洲
英國
德國
法國
義大利
西班牙
荷蘭
比利時
瑞典
瑞士
波蘭
其他歐洲國家
亞太地區
中國
日本
印度
韓國
澳洲
印尼
泰國
馬來西亞
新加坡
越南
亞太其他地區
南美洲
巴西
阿根廷
哥倫比亞
智利
秘魯
南美洲其他地區
世界其他地區(RoW)
中東
沙烏地阿拉伯
阿拉伯聯合大公國
卡達
以色列
其他中東國家
非洲
南非
埃及
摩洛哥
其他非洲國家
企業概況
對其他市場參與者(最多 3 家公司)進行全面分析
對主要公司進行SWOT分析(最多3家公司)
區域細分
根據客戶要求,我們可以提供主要國家的市場估算和預測,以及複合年成長率(註:需經可行性確認)。
競爭性標竿分析
According to Stratistics MRC, the Global AI-Personalized Skincare Formulations Market is accounted for $1.4 billion in 2026 and is expected to reach $3.6 billion by 2034 growing at a CAGR of 12.5% during the forecast period. AI-personalized skincare formulations are products whose composition is determined by algorithms that analyze individual skin data such as questionnaires, selfies, and diagnostic device readings to select active ingredients and concentrations. These systems generate algorithm-selected serums, custom-blended moisturizers, and personalized acne, pigmentation, and barrier formulations. They are produced through automated blending and dispensing equipment and delivered as serums, creams, lotions, gels, and masks, with recurring reformulation based on follow-up assessments for dry, oily, and combination skin.
Personalization Expectation Shift
Consumers increasingly expect products tailored to their individual skin rather than mass-market formulations, which is driving adoption of algorithm-guided skincare. Diagnostic quizzes, smartphone imaging, and in-clinic devices generate data that brands convert into customized formulas, improving perceived relevance and satisfaction. Subscription models enable reformulation as skin conditions change, which strengthens retention. This shift from generic to individualized purchasing supports premium pricing and repeat revenue, thereby expanding the category across direct-to-consumer and professional channels.
Data Privacy and Validation Burden
AI-personalized skincare depends on collecting sensitive facial images and skin health data, which raises privacy compliance obligations across jurisdictions with strict data protection rules. Brands must implement consent management, secure storage, and transparent data-use policies, adding cost and complexity. Algorithm recommendations also require validation to ensure safety across skin types, yet independent evidence for improved outcomes remains limited. These privacy and validation burdens slow market entry and constrain claims, particularly in regulated European and Asian markets.
Automated Blending Infrastructure
Automated blending and dispensing systems create opportunity for brands to produce individualized formulas at scale without manual compounding, reducing labor cost and enabling distributed manufacturing near customers. Modular production units can be deployed in retail stores, clinics, or regional fulfillment centers, shortening delivery times and improving freshness. As hardware costs decline and formulation libraries expand, brands can offer broader customization ranges. This infrastructure supports recurring subscription models and improves margin structure across direct-to-consumer and clinic channels.
Substitution by Curated Retail
Curated retail assortments and well-designed questionnaire-driven product matching offer a simpler, lower-cost path to perceived personalization. Many consumers accept curated recommendations without requiring custom-blended formulas, which limits willingness to pay premiums for algorithm-driven customization. If mainstream brands add guided diagnostic tools to existing product lines, dedicated personalized platforms may struggle to differentiate. Consequently, personalized brands must demonstrate measurable outcome advantages and superior adherence to defend pricing and retention.
The pandemic accelerated digital skincare engagement, as consumers shifted to online consultations and diagnostic quizzes when in-store shopping was restricted. During the crisis, brands expanded questionnaire-based customization and direct-to-consumer delivery, supporting early adoption. Post-pandemic, hybrid diagnostic models combining at-home data collection with in-clinic verification have reinforced demand, while brands invested in privacy infrastructure and formulation validation to address heightened scrutiny of data handling and claim substantiation.
The Custom-Blended Moisturizers segment is expected to be the largest during the forecast period
The Custom-Blended Moisturizers segment is expected to account for the largest market share during the forecast period, due to high daily usage frequency, broad consumer acceptance of personalized hydration, and suitability for subscription replenishment. Moisturizers are purchased more regularly than treatment serums, which supports recurring revenue and stable volumes. Algorithms can adjust lipid and humectant ratios based on skin type and seasonal change, delivering perceptible benefits. As brands scale blending infrastructure, custom moisturizers remain the category volume anchor, thereby sustaining leading revenue share.
The Serums segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Serums segment is predicted to witness the highest growth rate, driven by consumer preference for concentrated, fast-absorbing formats that address specific concerns identified through diagnostic algorithms. Serums allow brands to highlight personalized active selection and concentration at premium price points, which suits direct-to-consumer subscription models. As diagnostic accuracy improves and formulation libraries expand, serum customization accelerates faster than other product form segments across both consumer and clinic channels.
During the forecast period, the North America region is expected to hold the largest market share, due to high digital skincare engagement, mature direct-to-consumer infrastructure, and strong presence of personalized beauty platforms. The United States dominates regional revenue, supported by venture-funded startups, automated blending facilities, and consumer willingness to share diagnostic data. Pharmacy and specialty retail partnerships further expand access, reinforcing North America's leading position in AI-personalized skincare formulations.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to widespread smartphone penetration, rapid e-commerce growth, and strong interest in diagnostic-driven skincare across China, South Korea, Japan, and India. Local brands are launching AI-assisted customization platforms supported by automated blending partnerships. Expanding middle-class spending and dermatology clinic networks further support adoption, making Asia Pacific the fastest-growing regional market for AI-personalized skincare formulations.
Key players in the market
Some of the key players in AI-Personalized Skincare Formulations Market include L'Oreal S.A., The Estee Lauder Companies Inc., Beiersdorf AG, Shiseido Company, Limited, Unilever PLC, The Procter & Gamble Company, Kao Corporation, Kenvue Inc., Amorepacific Corporation, LG H&H Co., Ltd., Coty Inc., Natura &Co, Edgewell Personal Care Company, Galderma Group AG, Pierre Fabre Laboratories, and Rohto Pharmaceutical Co., Ltd.
In October 2026, L'Oreal S.A. expanded its AI-personalized skincare platform with algorithm-selected serums and automated blending units deployed in retail locations, supported by dermatological validation and distributed across North American and European markets.
In September 2026, Shiseido Company, Limited introduced a diagnostic-driven personalization service generating custom-blended moisturizers and barrier formulations, supported by smartphone imaging analysis and delivered through brand-owned e-commerce across Japan and Southeast Asia.
In August 2026, Beiersdorf AG launched personalized acne and pigmentation formulations based on questionnaire and device data, integrated with subscription replenishment and distributed through dermatology clinics and pharmacies across European markets.
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Netherlands
Belgium
Sweden
Switzerland
Poland
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Thailand
Malaysia
Singapore
Vietnam
Rest of Asia Pacific
South America
Brazil
Argentina
Colombia
Chile
Peru
Rest of South America
Rest of the World (RoW)
Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
Africa
South Africa
Egypt
Morocco
Rest of Africa
Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.